Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: Two‐dimensional electrophoresis and isotope‐coded affinity tags analysis with two‐dimensional chromatography
- 8 May 2003
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 3 (5) , 616-626
- https://doi.org/10.1002/pmic.200300410
Abstract
Bone is maintained by two cell types, bone‐forming osteoblasts and bone‐resorbing osteoclasts. Osteoblasts express two factors, osteoprotegerin and receptor activator of NF‐κB ligand (RANKL), inhibiting and promoting osteoclast differentiation, respectively. In contrast, modulators of bone resorption expressed by osteoclasts have not been so well studied enough. In the present study, we demonstrate proteome analysis of secreted proteins during osteoclast differentiation to elucidate the molecular mechanism of bone resorption and bone remodeling. To achieve this objective, we chose RAW264.7 cells with RANKL as a homogeneous osteoclast differentiation model and used two methods, two‐dimensional gel electrophoresis (2‐DE) and isotope‐coded affinity tags (ICAT) analysis with two‐dimensional liquid chromatography. We found 23 spots in 2‐DE and 19 proteins in ICAT analysis which were expressed differently during osteoclast differentiation. These two methods gave us closely related but different information about proteins, suggesting they are complementary or at least supplementary methods at present. Cathepsins, osteopontin, legumain, macrophage inflammatory protein‐1α, and other proteins were observed as up‐ or down‐regulated proteins and are discussed in the context of osteoclast differentiation and bone resorption. In addition to confirming previous observations, this study indicates novel proteins related to osteoclast differentiation which are potential therapeutic targets for the treatment of bone diseases, such as osteoporosis.Keywords
This publication has 45 references indexed in Scilit:
- Platelet-Derived Growth Factor BB Secreted From Osteoclasts Acts as an Osteoblastogenesis Inhibitory FactorJournal of Bone and Mineral Research, 2002
- Defective Antigen Processing in GILT-Free MiceScience, 2001
- Potent and Selective Cathepsin L Inhibitors Do Not Inhibit Human Osteoclast Resorption in VitroJournal of Biological Chemistry, 2001
- The mechanisms of estrogen regulation of bone resorptionJournal of Clinical Investigation, 2000
- Gamma-Interferon-inducibleLysosomal Thiol Reductase (GILT)Journal of Biological Chemistry, 2000
- A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and FunctionBiochemical and Biophysical Research Communications, 1999
- Cystatin C, an inhibitor of bone resorption produced by osteoblastsActa Physiologica Scandinavica, 1997
- Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human OsteoclastsJournal of Biological Chemistry, 1996
- ArgGlyAsp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts*1Experimental Cell Research, 1991
- Echistatin is a potent inhibitor of bone resorption in culture.The Journal of cell biology, 1990